Exact Mass: 302.0656

Exact Mass Matches: 302.0656

Found 78 metabolites which its exact mass value is equals to given mass value 302.0656, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Neo proserine

Neostigmine Bromide

C12H19BrN2O2 (302.063)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors

   

fludiazepam

fludiazepam

C16H12ClFN2O (302.0622)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Fludiazepam

1-Methyl-5-(2-fluorophenyl)-7-chloro-1,3-dihydro-2H-(1,4)benzodiazepin-2-one

C16H12ClFN2O (302.0622)


Fludiazepam is only found in individuals that have used or taken this drug. It is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a scheduled drug in the U.S., but is approved for use in Japan.Fludiazepam has similar action to diazepam, but binds with four times more affinity to benzodiazepine receptors than diazepam. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Pyrogallol-2-O-glucuronide

(2S,3S,4S,5R,6S)-6-(2,6-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C12H14O9 (302.0638)


Pyrogallol-2-O-glucuronide is a conjugate of Pyrogallol and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)

   

1,3-Bis(4-nitrophenyl)urea

urea, N,N-bis(4-nitrophenyl)-

C13H10N4O5 (302.0651)


   

Glutamate carbon

3,11-diamino-1,7,9,15-tetraoxaspiro[7.7]pentadecane-2,6,10,14-tetrone

C11H14N2O8 (302.075)


   

Pipes

2-[4-(2-sulfoethyl)piperazin-1-yl]ethane-1-sulfonic acid

C8H18N2O6S2 (302.0606)


   

Maybridge3_004502

Maybridge3_004502

C15H14N2O3S (302.0725)


   
   

PIPES

PIPES

C8H18N2O6S2 (302.0606)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; IHPYMWDTONKSCO-UHFFFAOYSA-N_STSL_0146_PIPES_2000fmol_180419_S2_LC02_MS02_24; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

(2-Chloro-6-methyl-quinolin-3-ylmethyl)-thiophen-2-ylmethyl-amine

(2-Chloro-6-methyl-quinolin-3-ylmethyl)-thiophen-2-ylmethyl-amine

C16H15ClN2S (302.0644)


   
   

Lachnanthofluorene

Lachnanthofluorene

C19H10O4 (302.0579)


   
   

PIPES; LC-tDDA; CE10

PIPES; LC-tDDA; CE10

C8H18N2O6S2 (302.0606)


   

PIPES; LC-tDDA; CE20

PIPES; LC-tDDA; CE20

C8H18N2O6S2 (302.0606)


   

PIPES; LC-tDDA; CE30

PIPES; LC-tDDA; CE30

C8H18N2O6S2 (302.0606)


   

PIPES; LC-tDDA; CE40

PIPES; LC-tDDA; CE40

C8H18N2O6S2 (302.0606)


   

5-Carboxymethyl-uridine; LC-tDDA; CE10

5-Carboxymethyl-uridine; LC-tDDA; CE10

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; LC-tDDA; CE20

5-Carboxymethyl-uridine; LC-tDDA; CE20

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; LC-tDDA; CE30

5-Carboxymethyl-uridine; LC-tDDA; CE30

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; LC-tDDA; CE40

5-Carboxymethyl-uridine; LC-tDDA; CE40

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE0; MS2Dec

5-Carboxymethyl-uridine; AIF; CE0; MS2Dec

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE10; MS2Dec

5-Carboxymethyl-uridine; AIF; CE10; MS2Dec

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE30; MS2Dec

5-Carboxymethyl-uridine; AIF; CE30; MS2Dec

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE0; CorrDec

5-Carboxymethyl-uridine; AIF; CE0; CorrDec

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE10; CorrDec

5-Carboxymethyl-uridine; AIF; CE10; CorrDec

C11H14N2O8 (302.075)


   

5-Carboxymethyl-uridine; AIF; CE30; CorrDec

5-Carboxymethyl-uridine; AIF; CE30; CorrDec

C11H14N2O8 (302.075)


   

Benzaldehyde,2-hydroxy-, 2-(2,4-dinitrophenyl)hydrazone

Benzaldehyde,2-hydroxy-, 2-(2,4-dinitrophenyl)hydrazone

C13H10N4O5 (302.0651)


   

10-(CYANOMETHYL)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID

10-(CYANOMETHYL)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID

C15H11FN2O4 (302.0703)


   
   

Benzenemethanol, a-(pentafluoroethyl)-a-phenyl- (9CI)

Benzenemethanol, a-(pentafluoroethyl)-a-phenyl- (9CI)

C15H11F5O (302.073)


   

2,2-Methylenebis(4-aminophenol) dihydrochloride

2,2-Methylenebis(4-aminophenol) dihydrochloride

C13H16Cl2N2O2 (302.0589)


   

4-(4-Chlorophenyl)-2-(4-methylphenyl)-4-oxobutanoic acid

4-(4-Chlorophenyl)-2-(4-methylphenyl)-4-oxobutanoic acid

C17H15ClO3 (302.071)


   

(S)-4-Bromo-4-(2-methylbutyl)-1,1-biphenyl

(S)-4-Bromo-4-(2-methylbutyl)-1,1-biphenyl

C17H19Br (302.067)


   

2-(3,5-Dichloro-4-methoxyphenyl)4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3,5-Dichloro-4-methoxyphenyl)4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BCl2O3 (302.0648)


   

6-chloro-2-(4-ethyl-3-nitrophenyl)imidazo[1,2-b]pyridazine

6-chloro-2-(4-ethyl-3-nitrophenyl)imidazo[1,2-b]pyridazine

C14H11ClN4O2 (302.057)


   

Ethyl 2-(4-fluorophenyl)-3-(trifluoromethyl)pyrazole-4-carboxylate

Ethyl 2-(4-fluorophenyl)-3-(trifluoromethyl)pyrazole-4-carboxylate

C13H10F4N2O2 (302.0678)


   

(2,4-DIPHENYL-1,3-THIAZOL-5-YL)METHYLAMINE HYDROCHLORIDE

(2,4-DIPHENYL-1,3-THIAZOL-5-YL)METHYLAMINE HYDROCHLORIDE

C16H15ClN2S (302.0644)


   

5-bromo-2,4-di-tert-butoxypyrimidine

5-bromo-2,4-di-tert-butoxypyrimidine

C12H19BrN2O2 (302.063)


   

1H-Pyrrolo[2,3-b]pyridine, 4-methoxy-1-[(4-methylphenyl)sulfonyl]-

1H-Pyrrolo[2,3-b]pyridine, 4-methoxy-1-[(4-methylphenyl)sulfonyl]-

C15H14N2O3S (302.0725)


   

Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)-

Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)-

C13H10F4N2O2 (302.0678)


   

4-(1-PYRROLIDINYL)-3-(TRIFLUOROMETHYL)BEZENAMINE DIHYDROCHLORIDE

4-(1-PYRROLIDINYL)-3-(TRIFLUOROMETHYL)BEZENAMINE DIHYDROCHLORIDE

C11H15Cl2F3N2 (302.0564)


   

N-(4-CYANO-BENZYL)-2-METHOXY-BENZENESULFONAMIDE

N-(4-CYANO-BENZYL)-2-METHOXY-BENZENESULFONAMIDE

C15H14N2O3S (302.0725)


   
   

Methyl [6-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyridinyl]ca rbamate

Methyl [6-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyridinyl]ca rbamate

C14H11ClN4O2 (302.057)


   

methyl 2-(2-methoxycarbonylphenyl)sulfanylbenzoate

methyl 2-(2-methoxycarbonylphenyl)sulfanylbenzoate

C16H14O4S (302.0613)


   

4-Bromo-4-n-pentylbiphenyl

4-Bromo-4-n-pentylbiphenyl

C17H19Br (302.067)


   

5-Carboxy-2,3-diphenyl-2H-tetrazol-3-ium chloride

5-Carboxy-2,3-diphenyl-2H-tetrazol-3-ium chloride

C14H11ClN4O2 (302.057)


   

9,10-Dihydro-9-oxa-10-phosphaphenanthrene-10-propanoic acid methyl ester 10-oxide

9,10-Dihydro-9-oxa-10-phosphaphenanthrene-10-propanoic acid methyl ester 10-oxide

C16H15O4P (302.0708)


   
   

5-chloro-3-methylpyridin-2-amine,hydrate

5-chloro-3-methylpyridin-2-amine,hydrate

C12H16Cl2N4O (302.0701)


   

tert-Butyl [(2-nitrophenyl)sulfonyl]carbamate

tert-Butyl [(2-nitrophenyl)sulfonyl]carbamate

C11H14N2O6S (302.0573)


   

6-chlorobenzo[4,5]iMidazo[1,2-f]phenanthridine

6-chlorobenzo[4,5]iMidazo[1,2-f]phenanthridine

C19H11ClN2 (302.0611)


   

Febuxostat isopropyl isomer

Febuxostat isopropyl isomer

C15H14N2O3S (302.0725)


   

6-Chloro-2-deoxyguanosine

6-Chloro-2-deoxyguanosine

C10H13ClN5O4 (302.0656)


   

2-Bromo-3-decylthiophene

2-Bromo-3-decylthiophene

C14H23BrS (302.0704)


   

2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL CHLORIDE

2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL CHLORIDE

C14H19ClO3S (302.0743)


   

1-[2-(Z)-Methoxyimino-2-(2-aminothiazol-4-yl)acetoxy]benzotrizole

1-[2-(Z)-Methoxyimino-2-(2-aminothiazol-4-yl)acetoxy]benzotrizole

C12H10N6O2S (302.0586)


   

cyclopenta-2,4-dien-1-yl(dimethyl)silicon,iron(2+)

cyclopenta-2,4-dien-1-yl(dimethyl)silicon,iron(2+)

C14H22FeSi2 (302.0609)


   

n-alpha-z-3-sulfamoyl-l-alanine

n-alpha-z-3-sulfamoyl-l-alanine

C11H14N2O6S (302.0573)


   

3-[(E)-[(2,4-dinitrophenyl)hydrazinylidene]methyl]phenol

3-[(E)-[(2,4-dinitrophenyl)hydrazinylidene]methyl]phenol

C13H10N4O5 (302.0651)


   

6-CHLORO-1-(PIPERIDIN-4-YL)-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE HYDROCHLORIDE

6-CHLORO-1-(PIPERIDIN-4-YL)-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE HYDROCHLORIDE

C13H16Cl2N2O2 (302.0589)


   

(S)-10-(Cyanomethyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid

(S)-10-(Cyanomethyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid

C15H11FN2O4 (302.0703)


   

5-Carboxymethyluridine

5-Carboxymethyluridine

C11H14N2O8 (302.075)


   

(E)-N-(3,5-dimethylphenyl)-3-(5-nitrothiophen-2-yl)prop-2-enamide

(E)-N-(3,5-dimethylphenyl)-3-(5-nitrothiophen-2-yl)prop-2-enamide

C15H14N2O3S (302.0725)


   

Pyrogallol-2-O-glucuronide

(2S,3S,4S,5R,6S)-6-(2,6-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C12H14O9 (302.0638)


Pyrogallol-2-O-glucuronide is a conjugate of Pyrogallol and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)

   

5,13-Diamino-1,7,9,15-tetraoxaspiro[7.7]pentadecane-2,6,10,14-tetrone

5,13-Diamino-1,7,9,15-tetraoxaspiro[7.7]pentadecane-2,6,10,14-tetrone

C11H14N2O8 (302.075)


   

2-(2-phenoxyethylsulfonyl)-1H-benzimidazole

2-(2-phenoxyethylsulfonyl)-1H-benzimidazole

C15H14N2O3S (302.0725)


   

4-Methyl-5-[2-[(phenylmethyl)amino]-4-thiazolyl]-2-thiazolamine

4-Methyl-5-[2-[(phenylmethyl)amino]-4-thiazolyl]-2-thiazolamine

C14H14N4S2 (302.066)


   

4-[[(4-Oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid

4-[[(4-Oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid

C15H14N2O3S (302.0725)


   

(E)-N-methyl-3-(2-nitrophenyl)-N-(thiophen-2-ylmethyl)prop-2-enamide

(E)-N-methyl-3-(2-nitrophenyl)-N-(thiophen-2-ylmethyl)prop-2-enamide

C15H14N2O3S (302.0725)


   

6-(2,4-Dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2,4-Dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C12H14O9 (302.0638)


   

Neostigmine Bromide

Neostigmine Bromide

C12H19BrN2O2 (302.063)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors

   

Pyrogallol-2-O-glucuronide

Pyrogallol-2-O-glucuronide

C12H14O9 (302.0638)


   

{1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-oxopyrimidin-5-yl}methyl formate

{1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-oxopyrimidin-5-yl}methyl formate

C11H14N2O8 (302.075)


   

10,14-dihydroxy-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(18),2(7),3,5,9(19),10,12(20),13,16-nonaen-15-one

10,14-dihydroxy-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(18),2(7),3,5,9(19),10,12(20),13,16-nonaen-15-one

C19H10O4 (302.0579)